Arphra/Issuer/AVTR

AVTR

Avantor, Inc.

HealthcareMedical - Instruments & SuppliesUSUSD

$9.00

LiveJun 01, 2026

AI Brief

Market cap

$6.14B

52w range

7.26 – 15.93

P / E

—

EPS

—

Volume

2.77M

Revenue · FY

$6.55B

-3.41% YoY

Explain this page

Arphra AIPlain-English read on Avantor, Inc.’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

0 txns

Net flow

+$0

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

No price history in prices_daily for AVTR.

Peers

No peer list available for AVTR.

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
-1.37%	+8.90%	+13.00%	-0.61%	-23.45%	-21.51%	-30.59%	-54.80%	-71.31%	-37.97%	-37.97%

Aftermarket

Live

Jun 01, 05:16 PM

Last trade

$8.99

780 sh

Bid

$8.97

9,500 sh

Ask

$9.00

904 sh

Spread

$0.030

Sector & industry today

Live

Sectors

Technology
+4.09%
Energy
+0.86%
Basic Materials
+0.68%
Industrials
+0.09%
Consumer Cyclical
+0.06%
Communication Services
-0.12%
Utilities
-0.33%
Real Estate
-0.52%
Consumer Defensive
-0.84%
Healthcare
-1.06%
Financial Services
-1.11%

Top industries (issuer's industry highlighted)

Medical - Instruments & Supplies
-0.92%
Software - Infrastructure
+6.09%
Computer Hardware
+6.02%
Luxury Goods
-4.68%
Coal
+4.38%
Semiconductors
+3.89%
Medical - Healthcare Information Services
+3.43%
Paper, Lumber & Forest Products
-3.35%
Software - Application
+3.30%
Copper
+3.12%
Consulting Services
+3.11%
Agricultural Farm Products
+2.95%

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Analyst PT consensus: $9.44 (+4.95%)

Total assets

$11.79B

Total debt

$3.95B

Cash & equiv

$365.4M

Operating CF

$623.8M

Free cash flow

$495M

Buybacks

-$80.7M

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for AVTR.

Recent quarters

All financials →

Period	Revenue	Net income	EPS
Q1 Mar 2026	$1.58B	$43.3M	$0.06
Q4 Dec 2025	$1.66B	$52.4M	$0.08
Q3 Sep 2025	$1.62B	-$711.8M	$-1.04
Q2 Jun 2025	$1.68B	$64.7M	$0.09
Q1 Mar 2025	$1.58B	$64.5M	$0.09
Q4 Dec 2024	$1.69B	$500.4M	$0.73

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2025	$6.55B	-$246.2M	-$530.2M	$-0.78	-8.09%
FY 2024	$6.78B	$1.08B	$711.5M	$1.04	+10.49%
FY 2023	$6.97B	$696.4M	$321.1M	$0.47	+4.61%
FY 2022	$7.51B	$1.13B	$686.5M	$1.01	+9.14%
FY 2021	$7.39B	$972.2M	$572.6M	$0.85	+7.75%